Giugliani, R., Harmatz, P., Jones, S., Mendelsohn, N., Vellodi, A., Qiu, Y., . . . Pano, A. (2017). Evaluation of impact of anti-idursulfase antibodies during long-term idursulfase enzyme replacement therapy in mucopolysaccharidosis II patients. Mol Genet Metab Rep.
Dyfyniad Arddull ChicagoGiugliani, R., et al. "Evaluation of Impact of Anti-idursulfase Antibodies During Long-term Idursulfase Enzyme Replacement Therapy in Mucopolysaccharidosis II Patients." Mol Genet Metab Rep 2017.
Dyfyniad MLAGiugliani, R., et al. "Evaluation of Impact of Anti-idursulfase Antibodies During Long-term Idursulfase Enzyme Replacement Therapy in Mucopolysaccharidosis II Patients." Mol Genet Metab Rep 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.